about
Medullary sponge kidney and testicular dysgenesis syndrome: a rare association.Macrostructural alterations of subcortical grey matter in psychogenic erectile dysfunction.Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells.Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progressionCancer multitarget pharmacology in prostate tumors: tyrosine kinase inhibitors and beyond.Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions.Efficacy and safety of Elevate® system on apical and anterior compartment prolapse repair with personal technique modification.PSA supernormalisation: a surrogate of complete adenoma removal in men with benign prostatic hyperplasia.Serum 25(OH)D seasonality in urologic patients from central Italy.Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia.Bicalutamide demonstrates biologic effectiveness in prostate cancer cell lines and tumor primary cultures irrespective of Her2/neu expression levels.Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment.Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors.Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma.Does transrectal color Doppler ultrasound improve the diagnosis of prostate cancer?Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients.In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.Female sexual function evaluation of the tension-free vaginal tape (TVT) and transobturator suburethral tape (TOT) incontinence surgery: results of a prospective study.Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways.Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells.Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro.Transobturator surgery in presence of corona mortis: a study in 13 women.Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells.Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement.Use of transvaginal ultrasound in females with primary bladder neck obstruction. A preliminary study.Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer.Periprostatic nerve block before ultrasound-guided prostate biopsy: a comparison of two local anesthetics.Reduction of prostate-specific antigen after tamsulosin treatment in patients with elevated prostate-specific antigen and lower urinary tract symptoms associated with low incidence of prostate cancer at biopsy.Penile rehabilitation therapy following radical prostatectomy.Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures.Integrated staging systems for conventional renal cell carcinoma: a comparison of two prognostic models.Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.A refined combined antero-retrograde approach for the resolution of a complex ureterovaginal fistula: an endourologic case report.Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity.Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386.Surgical and biologic outcomes after neoadjuvant bicalutamide treatment in prostate cancer.
P50
Q30440389-1FA8EABC-D9DD-4439-8FF9-198BAE07366EQ34314201-97EBDF30-7216-4377-8445-DF6411A8ECDEQ34756844-59F4CE5D-26D3-46DB-862F-DB9B55F6DB79Q35111816-D9C050E7-5FB0-43D9-8E74-DFE0C4304E4AQ37886244-339C9D97-F0D5-409C-9E9B-21A59039471FQ38784726-86863730-59BC-407F-B3E1-359E887ADB12Q38925371-33E9F0DF-409D-49AC-8B78-540DC6B3FD32Q39270734-ABB2D856-CCCF-49C4-9F73-51C907520750Q39591963-2AE4A078-D999-4C97-905C-A807159361FAQ39674898-779C125B-8CC3-411E-82B9-3822C7FCE2BFQ39873082-3CC17685-1FD4-46BA-BE7A-EF96C50AAD83Q39915300-0808BB79-6919-484C-8E52-2ABCD4A2C9B8Q39999306-45092D9D-6284-4273-B810-BBD867E8D173Q40005120-AAF06126-5F73-4D14-B61E-07A15EEC1C73Q40010738-6CEA8616-C3EE-402A-9F06-F5A83475261FQ40038119-3DD70500-E0FD-493B-ABC6-595BB21416C8Q40072269-1EAB99C0-649F-41DD-B3DD-5BD3F0CA63ACQ40114375-D6045C9A-75D3-4BA4-8B7A-D1BF8819E028Q40128710-C50590DF-762E-40DB-AC29-7C521851C3AFQ40214011-547207FA-D98A-46D6-89CE-BF04AD465CABQ40231939-A8FDD954-5019-492E-998C-D1B7B6F7D9B1Q40294747-3C97249E-94A3-48BC-A536-788F9F3D3EC1Q40344879-C275F93C-1F7B-484B-A9C0-275728ABC223Q40454416-EC0B4CB0-5038-4516-910A-3B87B5FA96AAQ40460503-596A41A1-0D27-4971-97E0-6C50FCDA339FQ40510936-7ED0E913-4F12-4DE9-BEBA-3E39B5E87CDAQ40573946-F0B356C6-9599-4935-8010-B57151982BBFQ40698733-02C46BDC-D1B5-4E1D-934A-E034F5803791Q40762929-263728E3-98C6-4DDF-B1A2-7C71C2055D5BQ41866398-5B9C57B0-9B25-40C3-840A-C649DB593D2DQ42979309-DCA73821-DE0E-412C-A171-A2F965AF4F33Q43031850-ACAA0A8A-E0F7-4718-8E10-425296702CD0Q43161875-7CC98B8E-0D43-49EE-8BA3-9385FE0DD516Q44279633-2A0852F7-C960-4FF9-9DF2-C119561DB644Q45268344-AE7F7EC4-22BC-4FD0-A73D-F5C497D7156CQ46157345-AE26BA2C-4D09-4D67-BF62-860819D00484Q46173072-1C657A46-6731-4AF4-A4DE-924BBEEF44EAQ46451955-AF0DBEFA-1300-4A1D-89EB-47CD679EC2B6Q46579417-ACA511B5-BE24-4C10-937D-6F359594E83CQ46908344-D0345B90-4F10-4EEE-90A3-C1508917CC7F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carlo Vicentini
@ast
Carlo Vicentini
@en
Carlo Vicentini
@es
Carlo Vicentini
@nl
type
label
Carlo Vicentini
@ast
Carlo Vicentini
@en
Carlo Vicentini
@es
Carlo Vicentini
@nl
prefLabel
Carlo Vicentini
@ast
Carlo Vicentini
@en
Carlo Vicentini
@es
Carlo Vicentini
@nl
P106
P1153
7005372963
P21
P31
P496
0000-0003-0776-0312